Who is the CEO of Rarity Bioscience?

Linus Bosaeus is the Chief Executive Officer of Rarity Bioscience.

What does Rarity Bioscience do?

Rarity Bioscience provides ultrasensitive multiplex assays, specifically the superRCA technology, for detecting rare nucleic acid sequences and DNA mutations in liquid biopsy or tissue samples.

How many employees does Rarity Bioscience have?

Rarity Bioscience has approximately 23 employees.

Where is Rarity Bioscience headquartered?

Rarity Bioscience is headquartered at Uppsala Science Park in Uppsala, Sweden.

What industry is Rarity Bioscience in?

Rarity Bioscience operates in Biotechnology.

Is Rarity Bioscience still active?

Yes, Rarity Bioscience was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.

How do I sell to Rarity Bioscience?

Research Rarity Bioscience's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details.

Data Surfer

How it works Insights Pricing FAQ Contact Login

Rarity Bioscience

Biotechnology

Uppsala, Sweden

23 employees

raritybioscience.com

Verified active February 2, 2026

Key Highlights

Founded in 2021, a biotechnology company.
Develops ultra-sensitive mutation detection assays.
Utilizes proprietary superRCA technology.
Focuses on liquid biopsy analysis.
Serves research, pharma, and laboratory clients.

About Rarity Bioscience

Rarity Bioscience specializes in developing ultra-sensitive multiplex assays for mutation detection in liquid biopsies. Their proprietary superRCA technology, based on padlock probes and rolling circle amplification, achieves exceptional sensitivity and specificity for analyzing blood and other biological samples. The company serves the research, pharmaceutical, and laboratory sectors, offering advanced solutions for genetic analysis. By leveraging established high-throughput flow cytometry for readout, Rarity Bioscience provides reliable and efficient tools for critical diagnostic and research applications. Founded in 2021 from groundbreaking research at Uppsala University, Rarity Bioscience is a privately held biotechnology firm committed to advancing precision medicine through innovative detection technologies.

Leadership Team

Linus Bosaeus

Chief Executive Officer

Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.

Company Facts

Ownership Private Company

Technology Stack

superRCA

Office Locations

BMC (former location)

Why Contact Rarity Bioscience?

Rarity Bioscience delivers ultra-sensitive and specific mutation detection in liquid biopsies using advanced superRCA technology, enabling groundbreaking research and diagnostics for the biotechnology and pharmaceutical industries.

Who Should Contact Rarity Bioscience for Business?

Research institutions, pharmaceutical companies, and diagnostic laboratories seeking advanced, highly sensitive mutation detection solutions for liquid biopsies.

More Biotechnology Companies

BRIC - Centre for DNA Fingerprinting and Diagnostics (CDFD)

255 employees

Kedrion Biopharma US

262 employees

sutro biopharma, inc.

258 employees

View all Biotechnology companies

Frequently Asked Questions

Who is the CEO of Rarity Bioscience?: Linus Bosaeus is the Chief Executive Officer of Rarity Bioscience.
What does Rarity Bioscience do?: Rarity Bioscience provides ultrasensitive multiplex assays, specifically the superRCA technology, for detecting rare nucleic acid sequences and DNA mutations in liquid biopsy or tissue samples.
How many employees does Rarity Bioscience have?: Rarity Bioscience has approximately 23 employees.
Where is Rarity Bioscience headquartered?: Rarity Bioscience is headquartered at Uppsala Science Park in Uppsala, Sweden.
What industry is Rarity Bioscience in?: Rarity Bioscience operates in Biotechnology.
Is Rarity Bioscience still active?: Yes, Rarity Bioscience was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to Rarity Bioscience?: Research Rarity Bioscience's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.